DexCom Aktie
62,20
EUR
-0,20
EUR
-0,32
%
71,26
USD
+2,40
USD
+3,49
%
DexCom jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
DexCom Aktie Analyse
| 02.08.18 | DexCom Buy | Canaccord Adams | |
| 03.05.18 | DexCom Buy | Canaccord Adams | |
| 23.03.18 | DexCom Outperform | Robert W. Baird & Co. Incorporated | |
| 28.09.17 | DexCom Outperform | Wedbush Morgan Securities Inc. | |
| 03.05.17 | DexCom Buy | Canaccord Adams | |
| 02.11.16 | DexCom Buy | Canaccord Adams | |
| 24.02.16 | DexCom Buy | The Benchmark Company | |
| 06.08.15 | DexCom Buy | Canaccord Adams | |
|
Werbung
|
|||
| 08.07.15 | DexCom Outperform | Robert W. Baird & Co. Incorporated | |
| 24.10.06 | DexCom Outperform | Piper Jaffray | |
Werbung
Werbung